双链核糖核酸病毒的研究 Ⅱ.家蚕细胞质多角体病毒免疫学的研究

按前报用分子筛凝胶柱层析纯化家蚕细胞质多角体病毒(Cytoplasmic polyhedrosis virus,以下简称CPV)作为抗原制备了兔抗血清。对接种CPV后不同时间的家蚕中肠组织内CPV的增殖过程进行了观察,表明利用免疫对流电泳在CPV感染后的12～20小时(即病毒在病蚕中肠组织内增殖初期)就可检出。家蚕CPV的抗血清与其他几种昆虫的CPV有免疫交叉反应,但当家蚕CPV的抗血清经双链多聚核苷酸(肌苷酸/胞嘧啶核苷酸,即poly I/poly C)吸收后,则与其他几种昆虫CPV的交叉反应即行消失。     

以CpG为佐剂的犬细小病毒基因疫苗的初步研究

目的研制犬细小病毒(CPV)基因疫苗。方法以CPV VP2基因为基因免疫的目的基因,以pcDNA3和pcDNAK质粒为基因免疫的载体,以非甲基化的胞嘧啶鸟嘌呤二核苷酸(CpG)为核心的免疫刺激序列为免疫佐剂,构建重组质粒并免疫BALB/c小鼠和毕格犬。结果经pcDNA3-VP2C1(含1个拷贝CpG基序)基因免疫的BALB/c小鼠能产生抗CPV血凝抑制抗体;对于经CPV灭活苗初次免疫的毕格犬,用pcDNAK-VP2C2(含2个拷贝CpG基序)质粒免疫产生的再次免疫应答优于pcDNA3-VP2C1。结论VP2基因、pcDNAK和犬源CpG可用于CPV基因疫苗的进一步研究。     

敏感性不同细胞系交替选育获得超高增殖率细小病毒株

迄今为止未见国际上有组织培养水貂肠炎病毒(MEV)、猫泛白细胞减少症病毒(FPLV)、犬细小病毒(CPV)的TCID_(50)高于log_(10)7.0或MEV的HA高于32~或CPV的HA高于4096~的报道。又据Goto(1986)报道,TCID_(50)为log10~(4-6)的CPV比MEV。FPLV的HA高20多倍,故HA为4096~的CPV液比HA为32~的MEV液中病毒含量还低。由此可见,PV培养效价低是目前国际上急待解决的重大问题。     

家蚕细胞质多角体病毒及其RNA

从感染细胞质多角体病毒(CPV)的家蚕的肠组织提取多角体,经碱处理后从中提纯了CPV。鉴定了CPV样品的紫外趿收特性、沉降性质,井在电镜下观察了CPV粒子的形态。从CPV提取的RNA经聚丙烯酰胺凝胶电泳鉴定,含有10个大小不同的片段。侵染件试验表明CPV具有侵染性,而CPV-RNA没有侵染性。     

替代宿主增殖松毛虫质型多角体病毒的比较研究

银纹夜蛾幼虫(Argyrogramma agnata)对松毛虫CPV(DpCPV)十分敏感,本文对两种不同的宿主增殖松毛虫CPV作了比较,电镜证实用替代宿主增殖的DpCPV与原毒株多角体(CPB)和病毒粒子的形态完全一致。3%PAGE分析二者的RNA图谱基本一致,有大小相同的2.98×10     

昆虫质型多角体病毒同义密码子使用模式分析

昆虫质型多角体病毒(cypovirus,CPV)是害虫种群重要调节因子,可用作生物防治剂。本研究采用多元统计分析方法对7种CPV进行密码子使用模式分析,结果表明:CPV密码子使用偏好性较弱,多数基因密码子使用模式受碱基组成影响,少数基因密码子使用模式除碱基组成外还有其它影响因素;中性绘图分析表明碱基组成主要受选择压力影响,受突变影响较小。同一电泳型CPV之间比同一宿主CPV之间共有的偏好性密码子多。CPV基因组内10个基因组片段之间密码子偏好性存在差异。CPV密码子偏好性与宿主昆虫密码子偏好性存在差异,所有CPV与其宿主昆虫共有的偏好性密码子均较少。对应分析进一步证明碱基组成是影响密码子使用的主要因素,不同电泳型CPV具有不同的密码子使用模式。聚类分析表明同一电泳型CPV密码子使用模式相似,同一宿主CPV密码子使用模式差异较大。     

抗犬细小病毒VP2蛋白单链抗体的制备与中和活性研究

为了减轻鼠源单克隆抗体(McAb)异源性引起的宿主免疫排斥反应,同时克服生产McAb成本高及费时费力等缺点,利用原核表达制备具有抗犬细小病毒(CPV)鼠源抗体可变区基因的单链抗体(single chain antibody fragment,ScFv)。提取实验室前期制备筛选的分泌具有良好中和活性抗CPV VP2蛋白McAb的杂交瘤细胞株总RNA,从反转录cDNA中扩增抗体重链可变区(VH)基因和轻链可变区(VL)基因并克隆到表达载体中,构建重组质粒p OPE101-ScFv;将重组质粒转化大肠杆菌进行诱导表达,通过蛋白免疫印迹(Western blot)实验、酶联免疫吸附试验(enzyme linked immunosorbent assay,ELISA)和间接免疫荧光试验(indirect immunofluorescence assay,IFA)证明,利用大肠杆菌表达系统获得的ScFv具有和CPV特异性结合的能力,且具有中和活性,效价为1:20(0. 028μg/ml),为CPV的临床免疫治疗提供基础。     

烟青虫质型多角体病毒的形态及某些理化特性

本文对烟青虫(Heliothis assulta)质型多角体病毒(CPV)的形态大小以及某些理化特性进行了研究。烟青虫CPV多角体为正五角形的十二面体,大小为0.8-4.6μm;CPV 粒子为外形呈六角形或球形的廿面体,大小为62nm。CPV多角体蛋白的主要多肽为一种,分子量23000,为非糖蛋白。 用SDS-酚法提取的CPV基因,经Rnase I和Dnase I处理后在1%琼脂糖凝胶上电泳,结果表明 其基因是双链RNA,并由10个基因片段组成。各片段大小为0.3-2.68X10⁶,总分子量为15.85x10⁶。本文所报道的烟青虫质型多角体病毒在国内外尚属首次。     

昆虫质型多角体病毒的研究进展

质型多角体病毒(Cytoplasmic polyhedrosis virus,CPV)隶属呼肠孤病毒科Reoviridae质型多角体病毒属Cypovirus,通常基因组由10个节段双链RNA构成。RNA分子量为3～27u。根据病毒基因组dsRNA片段在聚丙烯酰胺或琼脂糖凝胶中电泳图谱的差异,目前CPV已被分为19个电泳型。不同于呼肠孤病毒科其它成员,CPV为单层衣壳,而不是常见的双层衣壳结构,衣壳蛋白主要由衣壳蛋白、大突起蛋白及塔式突起蛋白组成。大部分质型多角体病毒引起昆虫慢性疾病,造成寄主死亡或适应性降低。随着RNA病毒基因序列测定技术的成熟,质型多角体病毒的序列测定方面取得较大进展,目前GenBank核苷酸序列数据库中已经公布了家蚕Bombyx mori CPV电泳型1两个株系(H株和I株)、舞毒蛾Lymantria dispar CPV电泳型1、舞毒蛾CPV电泳型14及粉纹夜蛾Trichoplusia ni CPV电泳型全基因组序列,为该病毒的进化与起源的研究提供更多的遗传信息。本文从结构功能、侵染特点、基因组特点及应用前景等方面综述了昆虫质型多角体病毒的研究进展。     

双链核糖核酸病毒的研究 Ⅲ.水稻普通矮缩病毒与家蚕细胞质多角体病毒间的免疫交叉反应

水稻普通矮缩病毒(RDV)的兔抗血清能分别与家蚕细胞质多角体病毒(CPV)颗粒及其双链RNA在免疫对流电泳中产生沉淀线。用水稻普通矮缩病毒的抗血清中和后的家蚕CPV的感染力与对照相比降低二个数量级。     

Intracellular Route of Canine Parvovirus Entry

The present study was designed to investigate the endocytic pathway involved in canine parvovirus (CPV) infection. Reduced temperature (18°C) or the microtubule-depolymerizing drug nocodazole was found to inhibit productive infection of canine A72 cells by CPV and caused CPV to be retained in cytoplasmic vesicles as indicated by immunofluorescence microscopy. Consistent with previously published results, these data indicate that CPV enters a host cell via an endocytic route and further suggest that microtubule-dependent delivery of CPV to late endosomes is required for productive infection. Cytoplasmic microinjection of CPV particles was used to circumvent the endocytosis and membrane fusion steps in the entry process. Microinjection experiments showed that CPV particles which were injected directly into the cytoplasm, thus avoiding the endocytic pathway, were unable to initiate progeny virus production. CPV treated at pH 5.0 prior to microinjection was unable to initiate virus production, showing that factors of the endocytic route other than low pH are necessary for the initiation of infection by CPV.     

Serologic response of captive coyotes (Canis latrans Say) to canine parvovirus and accompanying profiles of canine coronavirus titers

Fifty-five of 66 (83%) coyote pups from bitches vaccinated against canine parvovirus (CPV) were seropositive for CPV antibodies at birth. The CPV antibody titer in the pups declined with a half-life of 6.7 days until by the 8th week, only two of 41 (5%) pups were seropositive for CPV antibodies. At 8 wk, 41 of the pups were vaccinated against CPV (killed feline origin vaccine), but only one of 37 (3%) was positive for CPV antibodies at 11 wk. The 8-wk-old pups were either too young to respond to the CPV vaccine; they had sufficient undetectable, maternally-derived CPV antibodies to block active immunization; 3 wk was not a sufficient time for an immunological response from the pups; or the vaccine was poorly antigenic. Twenty of the 66 pups (30%) were seropositive for canine coronavirus (CCV) antibodies at birth, and all but three of the 20 were whelped from bitches that were also seropositive for CCV antibodies. Vaccination of females prior to whelping appeared to provide protection to their pups from CPV-induced mortality.     

羊痘病毒P32基因真核表达载体的构建、表达及其免疫原性

通过PCR方法扩增全长P32基因和截去跨膜区的P32基因(MP32),将其分别克隆到真核表达载体pcDNA3.1( )和已插入CpG序列的pcDNA3.1-CpG中,构建pcDNA3.1-P32、pcDNA3.1-CpG-P32和pcDNA3.1-CpG-MP32质粒;用脂质体法转染BHK-21细胞,通过间接免疫荧光(IFA)试验验证其表达效果;经肌肉免疫注射健康BALB/c小鼠,用间接ELISA法检测抗体;在免疫后的第3、5周取免疫小鼠的脾细胞,用流式细胞仪检测CD4 和CD8 T细胞亚群.结果所构建的真核表达载体在BHK-21细胞中都能表达P32蛋白;免疫小鼠血清在免疫第2周后均能检测到羊痘特异性IgG抗体;免疫组小鼠脾脏CD4 T细胞数目和CD4 /CD8 T细胞比值明显高于对照组.结果提示,所构建的真核载体可诱导小鼠产生特异性体液免疫应答,并能刺激小鼠产生较强的细胞免疫应答.     

Role of recycling endosomes and lysosomes in dynein-dependent entry of canine parvovirus

Canine parvovirus (CPV) is a nonenveloped virus with a 5-kb single-stranded DNA genome. Lysosomotropic agents and low temperature are known to prevent CPV infection, indicating that the virus enters its host cells by endocytosis and requires an acidic intracellular compartment for penetration into the cytoplasm. After escape from the endocytotic vesicles, CPV is transported to the nucleus for replication. In the present study the intracellular entry pathway of the canine parvovirus in NLFK (Nordisk Laboratory feline kidney) cells was studied. After clustering in clathrin-coated pits and being taken up in coated vesicles, CPV colocalized with coendocytosed transferrin in endosomes resembling recycling endosomes. Later, CPV was found to enter, via late endosomes, a perinuclear vesicular compartment, where it colocalized with lysosomal markers. There was no indication of CPV entry into the trans-Golgi or the endoplasmic reticulum. Similar results were obtained both with full and with empty capsids. The data thus suggest that CPV or its DNA was released from the lysosomal compartment to the cytoplasm to be then transported to the nucleus. Electron microscopy analysis revealed endosomal vesicles containing CPV to be associated with microtubules. In the presence of nocodazole, a microtubule-disrupting drug, CPV entry was blocked and the virus was found in peripheral vesicles. Thus, some step(s) of the entry process were dependent on microtubules. Microinjection of antibodies to dynein caused CPV to remain in pericellular vesicles. This suggests an important role for the motor protein dynein in transporting vesicles containing CPV along the microtubule network.     

Effect of double infection of cowpox virus-infected cells with paramyxovirus (Sendai virus) on formation of cowpox virus-specific cell surface antigen.

The formation of cowpox virus-specific cell surface antigen (CPV S-ag) was significantly enhanced by double infection with HVJ (Sendai virus). Simultaneous double infection, superinfection with HVJ and superinfection with CPV of cells persistently infected with HVJ similarly enhanced the formation of CPV S-ag, while pre-infection with HVJ was ineffective. To be effective, cells must be infected at a m.o.i. of greater than or equal to 1.0 and HVJ gene functions had to be expressed. The HVJ-infected cell extracts had an ability to accelerate uncoating (or degradation) of CPV, causing an early increase and a subsequent decrease in the infectivity of CPV. This activity reached a maximum 4--6 hr after HVJ infection, the increase paralleling enhancement of the total activity of several cellular enzymes. Addition of puromycin abolished the increase of these activities and the formation of CPV S-ag. Thus, the double infection with HVJ of CPV-infected cells induces an enhancement of CPV S-ag formation presumably as a consequence of activation of cellular enzymes which in turn accelerates uncoating of CPV.     

Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus.

Analysis of canine parvovirus (CPV) isolates with a panel of monoclonal antibodies showed that after 1986, most viruses isolated from dogs in many parts of the United States differed antigenically from the viruses isolated prior to that date. The new antigenic type (designated CPV type 2b) has largely replaced the previous antigenic type (CPV type 2a) among virus isolates from the United States. This represents the second occurrence of a new antigenic type of this DNA virus since its emergence in 1978, as the original CPV type (CPV type 2) had previously been replaced between 1979 and 1981 by the CPV type 2a strain. DNA sequence comparisons showed that CPV types 2b and 2a differed by as few as two nonsynonymous (amino acid-changing) nucleotide substitutions in the VP-1 and VP-2 capsid protein genes. One mutation, resulting in an Asn-Asp difference at residue 426 in the VP-2 sequence, was shown by comparison with a neutralization-escape mutant selected with a non-CPV type 2b-reactive monoclonal antibody to determine the antigenic change. The mutation selected by that monoclonal antibody, a His-Tyr difference in VP-2 amino acid 222, was immediately adjacent to residue 426 in the three-dimensional structure of the CPV capsid. The CPV type 2b isolates are phylogenetically closely related to the CPV type 2a isolates and are probably derived from a common ancestor. Phylogenetic analysis showed a progressive evolution away from the original CPV type. This pattern of viral evolution appears most similar to that seen in some influenza A viruses.     

犬细小病毒中国内蒙株VP2基因克隆及序列分析

从我国内蒙古地区流行的犬细小病毒病病犬的肠溶物中分离提纯犬细小病毒（ＣＰＶ）。提取病毒基因组ＤＮＡ,并以此ＤＮＡ为模板,采用人工合成的引物进行ＰＣＲ扩增,ＰＣＲ产物经ＢａｍＨＩ、ＳａｃＩ双酶切后,克隆于ｐＵＣ１９质粒的ＢａｍＨＩ／ＳａｃＩ位点。重组质粒ｐＵＣＶＰ２经ＰＣＲ鉴定、限制酶切分析和序列分析,结果表明：获得了犬细小病毒内蒙株（ＣＰＶ－ＩＭ）ＶＰ２基因的全长克隆,ＶＰ２基因全长１７５５ｎｔ,     

Evaluation of a Community’s Risk for Canine Parvovirus and Distemper Using Antibody Testing and GIS Mapping of Animal Shelter Intakes

This cross-sectional study aimed to identify where dogs with negative antibody tests to canine parvovirus (CPV) and canine distemper virus (CDV) originated when entering a community shelter, using a commercially available ELISA antibody test and Geographic Information Systems mapping. Of 2745 canines entering during a three-month period, 1056 test results were obtained. Dogs or puppies weighing over 2 lb were eligible if they could be humanely, nonchemically restrained for phlebotomy. Age and minor health issues weren't exclusions. Dogs were excluded if trained personnel were concerned health would be compromised by phlebotomy. Blood samples were collected within 24 hours of entry. Four hundred and twenty-seven (40%) dogs had positive antibody test results for both viruses, 422 (40%) were positive for CPV, 37 (4%) were positive for CDV, and 170 (16%) were negative for both. Mapping revealed geographic patterns for dogs with negative antibody tests. This shelter admitted dogs with negative CPV and/or CDV antibody tests from defined community areas. Targeting vaccination efforts in communities to areas where dogs with negative antibody tests originate could be an effective wellness strategy.     

犬细小病毒VP2基因的克隆及其在毕赤酵母中的表达

目的表达犬细小病毒VP2蛋白（CPVVP2）,用于犬细小病毒病的诊断、疫苗研制和VP2蛋白功能研究。方法采用PCR方法对CPVVP2基因进行扩增,将CPVVP2基因克隆到毕赤酵母（Pichiapastoris）分泌表达载体pPICZαA中,构建真核重组表达载体pPICZαA—VP2,将该重组质粒线性化后,转化毕赤酵母菌GS115中,在甲醇诱导下表达CPVVP2,SDS-PAGE和Western blotting鉴定表达蛋白。结果成功扩增了CPVVP2基因,构建了真核重组表达载体pPICZαA-VP2在毕赤酵母菌中表达出约64．35kD蛋白。Western blotting鉴定表明,表达VP2蛋白与犬细小病毒阳性血清有反应性。结论在毕赤酵母中成功地表达了CPVVP2蛋白,能被犬细小病毒阳性血清识别。     

Prevalence of antibodies against canine parvovirus and canine distemper virus in wild coyotes in southeastern Colorado.

Serum from 72 wild coyotes (Canis latrans) in southeastern Colorado (USA) was collected and analyzed for prevalence of antibody to canine parvovirus (CPV) and canine distemper virus (CDV) from 1985 to 1988. The prevalence of antibodies to CPV and CDV was 71% and 57%, respectively, for the 4 yr of the study. Prevalence of antibody to CPV did not differ among years, between sexes, or with age. Prevalence of antibody to CDV did not differ among years or between sexes, but was significantly higher in adults (62%) than juveniles (33%). Prevalence of antibodies against CPV and CDV in southeastern Colorado was comparable to results reported in other serologic surveys in the western United States.